Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study

OBJECTIVE: The risk of cardiovascular morbidity and mortality is significantly increased in patients with diabetes; thus, it is important to determine whether glucose-lowering therapy affects this risk over time. Changes in cardiovascular risk markers were examined in patients with type 2 diabetes t...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cardiovasc Diabetol
Главные авторы: Simó, Rafael, Guerci, Bruno, Schernthaner, Guntram, Gallwitz, Baptist, Rosas-Guzmàn, Juan, Dotta, Francesco, Festa, Andreas, Zhou, Ming, Kiljański, Jacek
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2015
Предметы:
Original Investigation
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4558893/
https://ncbi.nlm.nih.gov/pubmed/26338040
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-015-0279-z
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы